Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Cash from Investing Activities (2023 - 2024)

Coeptis Therapeutics Holdings has reported Cash from Investing Activities over the past 2 years, most recently at $100000.0 for Q4 2024.

  • Quarterly results put Cash from Investing Activities at $100000.0 for Q4 2024, changed N/A from a year ago — trailing twelve months through Sep 2025 was $100000.0 (up 200.0% YoY), and the annual figure for FY2021 was -$1.8 million, up 97.69%.
  • Cash from Investing Activities for Q4 2024 was $100000.0 at Coeptis Therapeutics Holdings, up from -$100000.0 in the prior quarter.
  • Over the last five years, Cash from Investing Activities for COEPW hit a ceiling of $350000.0 in Q3 2023 and a floor of -$350000.0 in Q2 2023.